Clinical Trial Update: Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV [Phase 1, Phase 2]

View source ↗

Summary

Phase I-B/Phase II trial evaluating the safety, tolerability and efficacy of IZN-6NVS for Atrophic Vaginitis; study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrophic Vaginitis

Drugs mentioned

• IZN-6NVS

Snippet

Sponsor: Izun Pharma Ltd | Conditions: Atrophic Vaginitis | Phase 1, Phase 2 | Status: COMPLETED